Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

80 projects found matching your search criteria :

  1. Amino acids among biomarkers for blood pressure level – causal inference using molecular, epidemiological, and genetic a...

    Call: OPUS 23 , Panel: NZ4

    Principal investigator: dr hab. Mateusz Siedliński

    Uniwersytet Jagielloński, Collegium Medicum

  2. The effect of physical activity on the tissue nitric oxide (NO) bioavailability and mitochondrial biogenesis in skeletal...

    Call: OPUS 14 , Panel: NZ7

    Principal investigator: prof. Joanna Majerczak

    Uniwersytet Jagielloński, Collegium Medicum

  3. The assessment of cysteinyl leukotriene receptor antagonist role in inhibition of atherosclerosis, proliferation and its...

    Call: OPUS 17 , Panel: NZ5

    Principal investigator: dr hab. Paweł Maga

    Uniwersytet Jagielloński, Collegium Medicum

  4. Determination of the SNAIL1 transcription factor effect on biology cancer stem cells in rhabdomyosarcoma model

    Call: OPUS 24 , Panel: NZ5

    Principal investigator: prof. Marcin Majka

    Uniwersytet Jagielloński, Collegium Medicum

  5. Search for novel IKK-β inhibitors in the context of diseases with neuroinflammatory origin – structure-based drug design...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Emilia Sługocka

    Uniwersytet Jagielloński, Collegium Medicum

  6. Targeting the serotonin 5-HT7 receptor in a search for new strategies of mental disorders treatment

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Patryk Pyka

    Uniwersytet Jagielloński, Collegium Medicum

  7. Fibrin clot properties in patients with complete or partial respiratory failure during qualification and after 3 months ...

    Call: PRELUDIUM BIS 5 , Panel: NZ5

    Principal investigator: dr hab. Michał Ząbczyk

    Uniwersytet Jagielloński, Collegium Medicum

  8. Vascular dysfunction after breast cancer neoadjuvant chemotherapy.The significance of menopausal status and estrogens.

    Call: SONATA 19 , Panel: NZ4

    Principal investigator: dr Piotr Szczepaniak

    Uniwersytet Jagielloński, Collegium Medicum

  9. The gut-fetal brain axis as a promising key to deciphering the developmental origins of autism spectrum disorders

    Call: SONATA 19 , Panel: NZ5

    Principal investigator: dr Kinga Gawlińska

    Uniwersytet Jagielloński, Collegium Medicum

  10. Multitarget approach to break the vicious circle of tau pathology and neuroinflammation in Alzheimer's disease: developm...

    Call: SONATA BIS 9 , Panel: NZ7

    Principal investigator: dr hab. Anna Więckowska

    Uniwersytet Jagielloński, Collegium Medicum

  11. Which patients with rheumatoid arthritis or axial spondyloarthritis without classical cardiovascular risk factors have m...

    Call: PRELUDIUM 18 , Panel: NZ5

    Principal investigator: Jarosław Nowakowski

    Uniwersytet Jagielloński, Collegium Medicum

  12. The role of microRNA delivered by Tumor derived Extracellular Vesicles in modulation of human monocytes activity.

    Call: OPUS 17 , Panel: NZ5

    Principal investigator: dr hab. Monika Baj-Krzyworzeka

    Uniwersytet Jagielloński, Collegium Medicum

  13. Role of Th17 cells in pathogenesis of abdominal aortic aneurysm.

    Call: PRELUDIUM 17 , Panel: NZ5

    Principal investigator: Dorota Studzińska

    Uniwersytet Jagielloński, Collegium Medicum

  14. Mechanisms of immunity directed against coronaviruses based on theanalysis of antibodies in convalescents, exposed/sub-c...

    Call: OPUS 20 , Panel: NZ6

    Principal investigator: prof. Piotr Heczko

    Uniwersytet Jagielloński, Collegium Medicum

  15. Intensity of a human immunological response for allergenic properties of subunits and fractions of silver birch (Betula ...

    Call: OPUS 21 , Panel: NZ8

    Principal investigator: dr hab. Dorota Myszkowska

    Uniwersytet Jagielloński, Collegium Medicum

  16. New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epil...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Marcin Jakubiec

    Uniwersytet Jagielloński, Collegium Medicum

  17. Anatomy and dynamics of changes in the morphology of the facial fat compartments in the model based on obese people afte...

    Call: SONATA 17 , Panel: NZ4

    Principal investigator: dr hab. Mateusz Koziej

    Uniwersytet Jagielloński, Collegium Medicum

  18. Dual 5-HT3 receptor/5-HT6 receptor antagonists in neuropsychiatric and neurological disorders

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: prof. Paweł Zajdel

    Uniwersytet Jagielloński, Collegium Medicum

  19. Establishing evidence-based strategic recommendations for patient-centred health care options for individuals experienci...

    Call: POLONEZ BIS 1 , Panel: NZ7

    Principal investigator: dr Iwona Bielska

    Uniwersytet Jagielloński, Collegium Medicum

  20. Combination of FAAH inhibition with action via serotonin 5-HT6 receptor as pioneering approach to fight with Alzheimer D...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Kinga Czarnota-Łydka

    Uniwersytet Jagielloński, Collegium Medicum

  21. New positive allosteric modulators of EAAT2 glutamate transporter as candidates for treatment of neurological and psychi...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Krzysztof Kamiński

    Uniwersytet Jagielloński, Collegium Medicum

  22. Modeling of the excipients effect on drug skin permeability

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Laura Krumpholz

    Uniwersytet Jagielloński, Collegium Medicum

  23. The supersaturated drug delivery systems (SDDS) as a universal platform to address the problem of poor drugs' solubility

    Call: SONATA BIS 9 , Panel: NZ7

    Principal investigator: dr hab. Anna Krupa

    Uniwersytet Jagielloński, Collegium Medicum

  24. '#Webimmunization. How can online social networks create collective resilience against misinformation?"

    Call: IDEALAB , Panel: HS6

    Principal investigator: dr Jan Piasecki

    Uniwersytet Jagielloński, Collegium Medicum

  25. Ethics of research with human subjects in precision medicine

    Call: PRELUDIUM 18 , Panel: HS1

    Principal investigator: Karolina Strzebońska

    Uniwersytet Jagielloński, Collegium Medicum

  26. Do potential new MRGPRX2 ligands induce mastocytes degranulation in human?

    Call: OPUS 18 , Panel: NZ5

    Principal investigator: dr hab. Grzegorz Porębski

    Uniwersytet Jagielloński, Collegium Medicum

  27. Towards innovative strategy for treatment of Alzheimer's Disease via dual inhibition of receptor 5-HT6 and kinase CDK5.

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Sylwia Sudoł

    Uniwersytet Jagielloński, Collegium Medicum

  28. Metabolomic and proteomic studies combined with modern magnetic resonance imaging techniques to explore mechanisms of br...

    Call: OPUS 19 , Panel: NZ5

    Principal investigator: prof. Przemko Kwinta

    Uniwersytet Jagielloński, Collegium Medicum

  29. Dual CBR1-AKR1C3 inhibitors as a new approach to improve effectiveness and safety of anthracycline therapy.

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Marek Jamrozik

    Uniwersytet Jagielloński, Collegium Medicum

  30. First-in-class dual modulators of necroptosis kinases and 5-HT6 receptors as an innovative approach to develop an effect...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Jadwiga Handzlik

    Uniwersytet Jagielloński, Collegium Medicum

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy